文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

纽约州成人按疫苗接种状态划分的新冠新发病例与住院率

New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-09-17

纽约州卫生部链接全州免疫、实验室检测和住院数据库,估计2021年5月3日至7月25日成人中实验室确诊新冠新发病例和住院率及疫苗有效性。所有成人年龄调整后针对新发病例的疫苗有效性从91.8%降至75.0%,针对住院的疫苗有效性相对稳定在89.5%至95.1%之间。当前授权疫苗对住院有高效力,但针对新发病例的有效性近月下降,与Delta变异株占比上升及口罩和社交距离措施放松同时发生。

要点

  • 全程接种对新冠住院的年龄调整疫苗有效性稳定在89.5%至95.1%。
  • 全程接种对新发病例的年龄调整疫苗有效性从91.8%降至75.0%。
  • 建议以疫苗接种为核心,结合口罩和社交距离等分层防控策略。

核心结论

  • 当前授权的新冠疫苗对预防住院有高效力,但针对新发病例的有效性近月下降。

研究设计与样本

  • 纽约州卫生部链接全州免疫、实验室检测和住院数据库,估计成人中实验室确诊新冠新发病例和住院率及全程接种的疫苗有效性。

主要发现

  • 2021年5月3日至7月25日,所有成人年龄调整后针对新发病例的疫苗有效性从91.8%降至75.0%。
  • 同期针对住院的年龄调整后疫苗有效性相对稳定,范围为89.5%至95.1%。

临床怎么用

  • 应实施以疫苗接种为中心、结合口罩和社交距离等其他预防措施的分层防控策略,以减少新冠新发病例和住院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Data from randomized clinical trials and real-world observational studies show that all three COVID-19 vaccines currently authorized for emergency use by the Food and Drug Administration* are safe and highly effective for preventing COVID-19-related serious illness, hospitalization, and death (1,2). Studies of vaccine effectiveness (VE) for preventing new infections and hospitalizations attributable to SARS-CoV-2, the virus that causes COVID-19), particularly as the B.1.617.2 (Delta) variant has become predominant, are limited in the United States (3). In this study, the New York State Department of Health linked statewide immunization, laboratory testing, and hospitalization databases for New York to estimate rates of new laboratory-confirmed COVID-19 cases and hospitalizations by vaccination status among adults, as well as corresponding VE for full vaccination in the population, across all three authorized vaccine products. During May 3-July 25, 2021, the overall age-adjusted VE against new COVID-19 cases for all adults declined from 91.8% to 75.0%. During the same period, the overall age-adjusted VE against hospitalization was relatively stable, ranging from 89.5% to 95.1%. Currently authorized vaccines have high effectiveness against COVID-19 hospitalization, but effectiveness against new cases appears to have declined in recent months, coinciding with the Delta variant's increase from <2% to >80% in the U.S. region that includes New York and relaxation of masking and physical distancing recommendations. To reduce new COVID-19 cases and hospitalizations, these findings support the implementation of a layered approach centered on vaccination, as well as other prevention strategies such as masking and physical distancing.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Rosenberg ES, Holtgrave DR, Dorabawila V, et al. New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34529645. doi:10.15585/mmwr.mm7037a7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。